Copyright
©The Author(s) 2018.
World J Gastroenterol. Apr 7, 2018; 24(13): 1451-1463
Published online Apr 7, 2018. doi: 10.3748/wjg.v24.i13.1451
Published online Apr 7, 2018. doi: 10.3748/wjg.v24.i13.1451
Figure 4 Receiver operating characteristic curve analysis based on the combination of fibrinogen and CA199 for overall survival.
AUC indicates the diagnostic power of the combination of fibrinogen and CA199. In this model, AUC was 0.765 (95%CI: 0.688-0.841). AUC: Area under curve.
- Citation: Xu WY, Zhang HH, Yang XB, Bai Y, Lin JZ, Long JY, Xiong JP, Zhang JW, Sang XT, Zhao HT. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients. World J Gastroenterol 2018; 24(13): 1451-1463
- URL: https://www.wjgnet.com/1007-9327/full/v24/i13/1451.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i13.1451